Related Experiment Videos
[Submucous hematoma of the cecum under anticoagulant therapy]
Journal De Chirurgie
|March 1, 1986
Abstract:
A patient developed an intramural hematoma of cecum as a result of indirect anticoagulant treatment. The case is remarkable with respect to the symptomatology and the very restricted extension of the lesion, these features probably resulting from a process of secondary infection.
Insights
Anticoagulant therapy can cause rare cecal intramural hematomas. This case highlights unusual symptoms and limited lesion size, possibly due to secondary infection.
Area of Science:
- Gastroenterology
- Hematology
- Internal Medicine
Background:
- Anticoagulant medications are widely used for thromboprophylaxis and treatment of thromboembolic disorders.
- Intramural hematomas are collections of blood within the wall of a hollow organ, which can occur in the gastrointestinal tract.
- Cecal hematomas are uncommon, particularly those associated with anticoagulant therapy.
Observation:
- A patient presented with symptoms suggestive of a gastrointestinal event.
- Imaging revealed a localized intramural hematoma of the cecum.
- The patient was undergoing indirect anticoagulant treatment at the time of presentation.
Findings:
- The cecal intramural hematoma was attributed to the patient's anticoagulant treatment.
- The clinical presentation and the lesion's restricted extent were considered remarkable.
- Secondary infection was hypothesized as a contributing factor to the specific characteristics of the hematoma.
Implications:
- This case expands the spectrum of gastrointestinal complications associated with anticoagulant therapy.
- Understanding the factors influencing hematoma presentation, such as secondary infection, is crucial for diagnosis and management.
- Further investigation into the pathogenesis of anticoagulant-induced intramural hematomas may inform clinical practice and patient monitoring.